Articles related to CLINICAL STUDY

This study evaluates the use of statins for primary prevention of cardiovascular diseases in adults aged 75 years and older, demonstrating a significant reduction in CVD incidence without an increase in severe adverse events. These findings provide real-world evidence to guide clinical decision-making in this underrepresented population.

Higher telehealth use correlates with increased healthcare utilization and costs, indicating that while telehealth improves access, it may also lead to higher rates of ambulatory care-sensitive hospitalizations.

High-risk iFISH markers, such as CKS1B, IGH-FGFR3, and del17p, significantly affect survival outcomes in newly diagnosed multiple myeloma patients, with marked differences observed between high-risk and standard-risk cohorts.

The study found that andexanet alfa significantly improves hemostatic efficacy in patients with intracerebral hemorrhage on factor Xa inhibitors but increases the risk of thrombotic events. These findings highlight the need for careful patient selection and monitoring when considering andexanet alfa in clinical practice.

This study from Cleveland Clinic highlights a counterintuitive trend where higher numbers of COVID-19 vaccine doses could lead to increased risk of infection, underscoring the complexity of immune responses and vaccine effectiveness over time.

Recent findings suggest that modifiable lifestyle factors such as education level and physical health measurably impact the risk of young-onset dementia. These insights are crucial for early intervention strategies in clinical practice.